AptarGroup, Inc.

ATR Healthcare Medical Instruments & Supplies

AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.

124.51 0.25 +0.20%
Market cap
$7.9B
P/E
22.2×
Fwd P/E
21.0×
Dividend yield
1.54%
F-score
5/9
Altman Z
3.78
Beneish M
−2.48
Dividend safety
92/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

21.05 20.43 21.32 22.36
P/S ratio
2.40 2.12 2.08 2.03
P/FCF ratio
28.45 26.90 24.56 25.33
P/Operating CF
49.45 43.65 68.00 76.99
P/B ratio
3.15 2.99 3.05 3.01
EV/Sales
2.65 2.41 2.38 2.32
EV/EBITDA
12.25 11.53 11.62 11.65
EV/FCF
31.48 30.50 28.02 29.05
Current Ratio
1.19 1.62 1.66 1.61
Net Debt/EBITDA
4.41 5.87 6.20 5.67
Debt/Equity
0.43 0.55 0.52 0.52
Earnings Yield
4.75% 4.90% 4.69% 4.47%
Free Cash Flow Yield
3.51% 3.72% 4.07% 3.95%
Free Cash Flow per Share
1.77 1.48 0.84 0.74
Book value per Share
42.42 40.86 41.34 41.59
Free Cash Flow
116.02 97.60 54.03 46.93
EV/EBIT
18.88 18.14 18.60 19.14
Other line items

Show all line items

Columns are period end dates